[Systemic therapy of colorectal carcinoma].
The therapeutic strategy for colorectal carcinoma is based upon the UICC stage. For stages 0 and I, endoscopic and operative methods are available. For stage II colon cancer, the indication for adjuvant chemotherapy has not been verified. On the other hand, beginning with stage III, the benefit of this therapy for lymph node metastases is undisputed. Although neoaduvant therapy is not indicated for colon cancer, it is standard procedure for rectal carcinoma in this stage. The objective of palliative chemotherapy in UICC stage IV is to extend the quality of life.
Kliniken Maria Hilf GmbH, Krankenhaus St. Franziskus, Klinik für Hämatologie, Onkologie und Gastroenterologie, Mönchengladbach.
A
A
Lang
U
U
Graeven
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D017024:Chemotherapy, Adjuvant; D003113:Colonoscopy; D015179:Colorectal Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology / Q000601:surgery; D003131:Combined Modality Therapy; D018572:Disease-Free Survival; D006801:Humans; D020360:Neoadjuvant Therapy; D009367:Neoplasm Staging; D010166:Palliative Care; D011379:Prognosis